Where Are They Now · Profile 09

Stephen Hahn

Stephen Hahn
Still from Epidemic of Fraud (00:05:22)

Stephen M. Hahn, MD ("Steve Hahn"), 24th Commissioner of Food and Drugs.

Claims are labeled Documented, Allegation or Open question. An allegation or open question is not a finding of wrongdoing.

Who he was in the COVID era

  • FDA Commissioner, Dec 2019–Jan 2021. Before that, chief medical executive at MD Anderson Cancer Center. Documented Sources: Nucleus RadioPharma bio; FDAweb
  • Hydroxychloroquine EUA. Granted Mar 28, 2020, and revoked Jun 15, 2020. FDA said the drugs were "unlikely to be effective" and that the risks outweighed the benefits. In the film, Hahn says the EUA was revoked "at the request of another government agency, BARDA." Documented Sources: FDA press release, Jun 15, 2020; AP; film 01:07:16
  • Remdesivir. In the film (00:55:09) he says: "We authorized Gilead's application for emergency use authorization. This was lightning speed…" Documented (film clip)
  • Convalescent plasma "35 out of 100" overstatement (Aug 23–25, 2020). At the White House plasma EUA announcement, he said plasma would save 35 of 100 patients. That misread a relative risk from an uncontrolled Mayo analysis. He apologized publicly on Aug 24–25. Documented
    • His apology was posted on @SteveFDA, which is now gone. Third-party post at the time: @FactsATruth, Aug 25, 2020. (third-party, low engagement)
    Sources: AP, "FDA chief apologizes for overstating plasma effect"; FactCheck.org; Axios
  • Pfizer and Moderna vaccine EUAs (Dec 2020) were issued on his watch. Documented Source: BreakBio release, Oct 26, 2026

In the film: clips and timecodes

  • 00:05:19 — "This is about science and data. There are randomized trials that show that it doesn't work. There are observational trials that show that it might work." (Hahn)
  • 00:13:05–00:13:34 — Chloroquine expanded use; "large pragmatic clinical trial" (Hahn, Mar 2020 briefing)
  • 00:46:56 — Narration quotes Hahn on genetic sequencing (FDA NGS test release) (Narration)
  • 00:55:09–00:55:21 — "We authorized Gilead's application for emergency use authorization. This was lightning speed…" (Hahn)
  • 01:07:16–01:07:30 — "we revoked an EUA… at the request of another government agency, BARDA…" (Hahn, NBC)
  • Full timecodes are in the annotated transcript.

How COVID-era money shows up in the record

  • The Moderna link after FDA: in 2021 he joined Flagship Pioneering, the venture firm that launched Moderna, as chief medical officer of its Preemptive Medicine initiative. He then became a Flagship CEO-Partner and CEO of Harbinger Health (2021–2025). This is a revolving-door fact. Documented Broken Truth flagged the Hahn–Flagship move (within about six months of leaving FDA) in its FOIA series on FDA's pharma revolving door. Broken Truth FOIA series, Jul 13, 2024 Sources: Nucleus RadioPharma bio; LinkedIn
  • Open question His Flagship and Harbinger compensation or equity is not public.

Consequences

  • None. No discipline or lawsuit against him personally was found. The plasma apology is the only formal walk-back on record. Documented (absence as of Nov 2, 2026 ET)

Where is he now

  • CEO and board member of Nucleus RadioPharma, a radiopharmaceutical CDMO. Documented Source: nucleusrad.com/about
  • Executive Clinical and Regulatory Lead at Turn Therapeutics (Nasdaq: TTRX), announced May 18, 2026. Documented Source: Turn Therapeutics release
  • Advisor to BreakBio, a personalized cancer drug company, announced Oct 26, 2026. Documented Source: EIN Presswire

Top sources

Last reviewed November 2026 (research pass Nov. 2–3, 2026). This profile is updated as new records surface. Corrections: Press@EpidemicOfFraud.com

← All profiles